EHDEN Webinar – What could the pharma industry look like by 2030 – digital discovery, R&D and post-authorisation?
Science is leading us down the path of increasingly targeted medicines with accompanying advances in genomics and our ability to develop personalised therapies for patients. However, there are increasing challenges in the development of drugs for ever smaller populations since, by definition, the rarer a disease is, the fewer people there are with the disorder … Read more